State Street’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-173,621
| Closed | -$75.5K | – | 4860 |
|
|
2022
Q4 | $75.5K | Hold |
173,621
| – | – | ﹤0.01% | 4450 |
|
|
2022
Q3 | $49K | Hold |
173,621
| – | – | ﹤0.01% | 4664 |
|
|
2022
Q2 | $63K | Buy |
173,621
+6,500
| +4% | +$2.36K | ﹤0.01% | 4677 |
|
|
2022
Q1 | $112K | Buy |
167,121
+9,921
| +6% | +$6.65K | ﹤0.01% | 4613 |
|
|
2021
Q4 | $203K | Buy |
157,200
+47,200
| +43% | +$61K | ﹤0.01% | 4346 |
|
|
2021
Q3 | $239K | Buy |
110,000
+30,900
| +39% | +$67.1K | ﹤0.01% | 4293 |
|
|
2021
Q2 | $216K | Buy |
+79,100
| New | +$216K | ﹤0.01% | 4192 |
|
|
2018
Q4 | – | Sell |
-10,677
| Closed | -$207K | – | 3797 |
|
|
2018
Q3 | $207K | Hold |
10,677
| – | – | ﹤0.01% | 3598 |
|
|
2018
Q2 | $193K | Sell |
10,677
-59,061
| -85% | -$1.07M | ﹤0.01% | 3572 |
|
|
2018
Q1 | $744K | Sell |
69,738
-1,517
| -2% | -$16.2K | ﹤0.01% | 3382 |
|
|
2017
Q4 | $3M | Buy |
71,255
+807
| +1% | +$34K | ﹤0.01% | 3024 |
|
|
2017
Q3 | $3.88M | Buy |
70,448
+2,083
| +3% | +$115K | ﹤0.01% | 2914 |
|
|
2017
Q2 | $12.7M | Buy |
68,365
+23,618
| +53% | +$4.38M | ﹤0.01% | 2273 |
|
|
2017
Q1 | $5.35M | Buy |
44,747
+572
| +1% | +$68.4K | ﹤0.01% | 2661 |
|
|
2016
Q4 | $4.39M | Buy |
44,175
+4,020
| +10% | +$400K | ﹤0.01% | 2762 |
|
|
2016
Q3 | $4.5M | Buy |
40,155
+1,879
| +5% | +$210K | ﹤0.01% | 2615 |
|
|
2016
Q2 | $3.93M | Buy |
38,276
+12,030
| +46% | +$1.24M | ﹤0.01% | 2744 |
|
|
2016
Q1 | $2.41M | Buy |
26,246
+3,041
| +13% | +$279K | ﹤0.01% | 2931 |
|
|
2015
Q4 | $3.35M | Buy |
23,205
+4,709
| +25% | +$679K | ﹤0.01% | 2759 |
|
|
2015
Q3 | $1.91M | Buy |
+18,496
| New | +$1.91M | ﹤0.01% | 3016 |
|